BioSpace News Archive

Business

Siemens Healthcare Appoints John Glaser CEO of Health IT Business

June 28, 2010
·
3 min read
Drug Development

ONGLYZA(TM) (saxagliptin) With Metformin as Initial Combination Therapy Provided 76-Week Long-Term Glycemic Control in Treatment-Naïve Adults With Type 2 Diabetes

June 28, 2010
·
1 min read
Business

Quintiles, Inc. to Invest in PRANA Biotechnology

June 28, 2010
·
5 min read
MannKind Corporation Release: AFREZZA(TM) Suppresses Endogenous Glucose Production More Rapidly Than Currently Available Insulin Therapy

June 28, 2010
·
1 min read
Drug Development

Analyst: Roche May Drop Taspoglutide Diabetes Drug

June 28, 2010
·
1 min read
Pharm Country

Antares Pharma, Inc. Added to Russell 3000 Index

June 28, 2010
·
1 min read
Biotech Beach

Somaxon Pharmaceuticals, Inc. Added to Russell 3000(R) Index, Russell 2000(R) Index, Russell Global(R) Index and Russell Microcap(R) Index

June 28, 2010
·
1 min read
Drug Development

Boehringer Ingelheim Corporation Announces Results of Phase III Data Showing That Linagliptin Significantly Lowered Blood Glucose with an Excellent Safety and Tolerability Profile

June 28, 2010
·
1 min read
BIOTECanada Release: Canadian, Global Leaders Discuss Green Energy, Biofuels, and Sustainable Solutions at World Congress on Industrial Biotechnology and Bioprocessing

June 28, 2010
·
1 min read
Drug Development

Boehringer Ingelheim Corporation Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes

June 28, 2010
·
9 min read